You just read:

Panacea Pharmaceuticals Initiates Phase I Study of First-in-Class Cancer Vaccine Therapy Candidate in Patients with Persistent Prostate Cancer

News provided by

Panacea Pharmaceuticals

Aug 13, 2062, 10:30 ET